<p>We report one case study of a malignant granular cell tumor patient with metabolic response to pazopanib. In this study, we used whole-genome sequencing of the tumor with the matched blood to characterize the somatic mutation profile in this tumor. This is the first reported whole-genome sequencing study of the rare malignant granular cell tumor.</p>

WGS of a Malignant GCT with Metabolic Response to Pazopanib

Granular Cell Tumor study with WGS data on dbGaP (1 participants)